309 related articles for article (PubMed ID: 12194790)
1. [Prognosis of non-small cell lung cancer patients with microscopic residual disease at bronchial stump after lung resection].
Dai W; Yu C; Sun Y
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(15):1022-4. PubMed ID: 12194790
[TBL] [Abstract][Full Text] [Related]
2. Survival according to the site of bronchial microscopic residual disease after lung resection for non-small cell lung cancer.
Collaud S; Bongiovanni M; Pache JC; Fioretta G; Robert JH
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):622-6. PubMed ID: 19258078
[TBL] [Abstract][Full Text] [Related]
3. Residual disease at the bronchial stump after curative resection for lung cancer.
Wind J; Smit EJ; Senan S; Eerenberg JP
Eur J Cardiothorac Surg; 2007 Jul; 32(1):29-34. PubMed ID: 17466532
[TBL] [Abstract][Full Text] [Related]
4. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
6. Importance of microscopic residual disease at the bronchial margin after resection for non-small-cell carcinoma of the lung.
Liewald F; Hatz RA; Dienemann H; Sunder-Plassmann L
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):408-12. PubMed ID: 1323002
[TBL] [Abstract][Full Text] [Related]
7. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
8. [Extent of lymphadenectomy in stage I-IIIA non-small cell lung cancer: a randomized clinical trial].
Wu Y; Wang S; Huang Z
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):43-5. PubMed ID: 11783068
[TBL] [Abstract][Full Text] [Related]
9. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
[TBL] [Abstract][Full Text] [Related]
10. [The study of peri-operative chemotherapy in stage I-IIIa NSCLC].
Liao ML; Zhou YZ; Ding JA; Ni GX; Zhao JM; Chen WH; Han BH; Shen J; Bai H; Chen ZW; Ji H; Wang HM; Zhou Z
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):962-6. PubMed ID: 12899797
[TBL] [Abstract][Full Text] [Related]
11. The side of pneumonectomy influences long-term survival in stage I and II non-small cell lung cancer.
Simón C; Moreno N; Peñalver R; González G; Alvarez-Fernández E; González-Aragoneses F;
Ann Thorac Surg; 2007 Sep; 84(3):952-8. PubMed ID: 17720406
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and prognosis of resected T3 non-small cell lung cancer.
Ilhan M; Demir A; Akin H; Zek Gunluoglu M; Olçmen A; Dncer SI
Minerva Chir; 2008 Apr; 63(2):101-8. PubMed ID: 18427442
[TBL] [Abstract][Full Text] [Related]
13. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
Ludwig C; Stoelben E; Olschewski M; Hasse J
Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
[TBL] [Abstract][Full Text] [Related]
14. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
Hosokawa Y; Matsuge S; Murakami Y; Satoh K; Yamazaki S; Kan T; Hatakeyama H
Kyobu Geka; 2000 Oct; 53(11):910-4. PubMed ID: 11048440
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with true pathologic stage I non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.
Merritt RE; Mathisen DJ; Wain JC; Gaissert HA; Donahue D; Lanuti M; Allan JS; Morse CR; Wright CD
Ann Thorac Surg; 2009 Nov; 88(5):1574-81; discussion 1581-2. PubMed ID: 19853115
[TBL] [Abstract][Full Text] [Related]
18. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
[TBL] [Abstract][Full Text] [Related]
19. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
20. Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis.
Riquet M; Achour K; Foucault C; Le Pimpec Barthes F; Dujon A; Cazes A
Ann Thorac Surg; 2010 Mar; 89(3):870-5. PubMed ID: 20172145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
